Screener
AnaptysBio, Inc. ANAB Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income | 2,653 | 4,413 |
| Non-cash interest expense for the sale of future royalties | (20,859) | (18,061) |
| Other (expense) income, net | (1) | 1,902 |
| Total other expense, net | (18,207) | (11,746) |
| Loss before income taxes | (52,844) | (39,285) |
| Provision for income taxes | (40) | (44) |
| Net loss | (52,884) | (39,329) |
| Other comprehensive loss: |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s other income (expense)?
- AnaptysBio, Inc. (ANAB) reported other income (expense) of -$18.21M in Q1 2026.
- How has AnaptysBio, Inc.'s other income (expense) changed year-over-year?
- AnaptysBio, Inc.'s other income (expense) decreased by 55.0% year-over-year, from -$11.75M to -$18.21M.
- What is the long-term trend for AnaptysBio, Inc.'s other income (expense)?
- Over 3 years (2021 to 2025), AnaptysBio, Inc.'s other income (expense) has grown at a 296.0% compound annual growth rate (CAGR), from -$982K to -$60.96M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about AnaptysBio, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude